Fibrinogen time course in acute ischemic stroke patients treated with intravenous thrombolysis with alteplase or tenecteplase
European Stroke Journal · 01.12.2025 · 10 (4) · 1364-1372
DOI: 10.1177/23969873251345387 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Stroke Journal, online erschienen am 01.12.2025. Verfasst von Aikaterini Theodorou und 16 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Attica, Gr…. Hauptthemen laut MEDLINE: Tissue Plasminogen Activator, Ischemic Stroke, Fibrinogen, Fibrinolytic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
Limited data exist on intravenous thrombolysis (IVT) effect on fibrinogen depletion, and on possible associations between low fibrinogen levels and hemorrhagic complications, among acute ischemic stroke (AIS) patients. Patients and methods: We conducted a prospective cohort study evaluating fibrinogen levels prior to IVT and at two prespecified timepoints following IVT end (2 and 24 h). Safety and efficacy outcomes were assessed. Fibrinogen depletion was defined as reduction < 200 mg/dl, or as reduction ⩾ 50% of baseline fibrinogen levels after 2 and 24 h from IVT. Furthermore, we conducted a systematic review and meta-analysis, comparing fibrinogen level changes from baseline to a timeframe of 2–12 h, and to 24 h post-IVT between patients receiving alteplase versus tenecteplase.
Results
One hundred and sixteen AIS patients, treated with IVT (alteplase = 81, tenecteplase = 35) were included in this study. Alteplase was associated with higher rates of fibrinogen depletion, observed in 2 (38% vs 0%; p-value < 0.001) and 24 h (26% vs 0%; p-value: 0.002) post-IVT, compared to tenecteplase. Three symptomatic intracranial hemorrhages (sICH) and one major extracranial bleeding were observed in patients receiving alteplase (two out of four with fibrinogen depletion) and one sICH without associated fibrinogen depletion was documented in the tenecteplase subgroup. Major hemorrhagic complications were numerically higher in patients with fibrinogen depletion (6.5% vs 3.5%, p = 0.609). Fibrinogen depletion was documented in 50% of alteplase-treated patients complicated with sICH or major extracranial bleeding and in 0% of respective tenecteplase-treated patients. Two cohorts were included in the meta-analysis. Mean relative changes of fibrinogen levels from baseline to a timeframe of 2–12 h post-IVT (RoM: 9.84; 95% CI: 9.63–10.05) were significantly higher in patients receiving alteplase. Discussion and conclusions: Fibrinogen depletion was observed only in AIS patients receiving alteplase and was associated with numerically higher rates of major hemorrhagic complications. These findings require independent confirmation in larger, international cohort studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Attica, Greece.
- Stroke Unit, Metropolitan Hospital, Piraeus, Greece.
- Second Critical Care Department, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Attica, Greece.
- Emergency Medicine Clinic, "Attikon" University Hospital, School of Medicine, National & Kapodistrian University of Athens, Athens, Attica, Greece.
- Neuroradiology Department, Metropolitan Hospital, Piraeus, Greece.
- Second Department of Radiology, Interventional Radiology Unit, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Attica, Greece.
ORCID-Profile: Aikaterini Theodorou, Odysseas Kargiotis, Konstantinos Melanis, Lina Palaiodimou, Guillaume Turc, Georgios Tsivgoulis
Zitieren
APA
Theodorou, A., Psychogios, K., Kargiotis, O., Safouris, A., Chondrogianni, M., Bakola, E., Melanis, K., Fanouraki, S., Frantzeskaki, F., Polyzogopoulou, E., Magoufis, G., Themistocleous, M., Palaiodimou, L., Stefanou, M. I., Turc, G., Alexandrov, A. V., & Tsivgoulis, G. (2025). Fibrinogen time course in acute ischemic stroke patients treated with intravenous thrombolysis with alteplase or tenecteplase. European Stroke Journal, 10(4), 1364-1372. https://doi.org/10.1177/23969873251345387
Vancouver
Theodorou A, Psychogios K, Kargiotis O, Safouris A, Chondrogianni M, Bakola E, et al. Fibrinogen time course in acute ischemic stroke patients treated with intravenous thrombolysis with alteplase or tenecteplase. European Stroke Journal. 2025;10(4):1364-1372. doi:10.1177/23969873251345387
BibTeX
@article{Theodorou2025,
author = {Theodorou, Aikaterini and Psychogios, Klearchos and Kargiotis, Odysseas and Safouris, Apostolos and Chondrogianni, Maria and Bakola, Eleni and Melanis, Konstantinos and Fanouraki, Stella and Frantzeskaki, Frantzeska and Polyzogopoulou, Eftihia and Magoufis, Georgios and Themistocleous, Marios and Palaiodimou, Lina and Stefanou, Maria-Ioanna and Turc, Guillaume and Alexandrov, Andrei V and Tsivgoulis, Georgios},
title = {Fibrinogen time course in acute ischemic stroke patients treated with intravenous thrombolysis with alteplase or tenecteplase},
journal = {European Stroke Journal},
year = {2025},
volume = {10},
number = {4},
pages = {1364--1372},
doi = {10.1177/23969873251345387}
}
EUVIMED